From Innovation to Access: Building Scalable Care Pathways for Next-Generation Therapies in Emerging Markets
Day 1 Global Pharma Outlook Stage
06/10/2026 16:45 - 17:25pm
Contributors
Sabine Kapasi : CEO, MD - Enira Consulting
Manish Khaitan : Head of the department, Bariatric and metabolic surgery - KND HOSPITAL
Shivtosh Kumar : Co-founder and CPO - Sugarfit
Saharsh Davuluri : CEO - Neuland
Reenita Das : Co-Founder, Chief Transformation Officer - NXT Horizon
Breakthrough therapies are redefining the future of healthcare, from GLP-1 and peptide innovations to advanced biologics, digital therapeutics, and precision medicine. Yet, innovation alone does not guarantee impact. The real challenge lies in translating scientific progress into scalable, affordable, and accessible care across diverse healthcare systems.
This session will explore what it takes to bridge the gap between innovation and real-world adoption, particularly in emerging markets where infrastructure, affordability, regulatory complexity, and patient adherence remain key barriers. The discussion will focus on how pharmaceutical companies, health systems, technology partners, and policymakers can work together to build delivery-ready ecosystems that ensure equitable access to next-generation therapies.
Key themes include:
- Market access and affordability strategies for advanced therapies.
- Healthcare system readiness and infrastructure challenges.
- Patient adherence and continuity of care.
- Role of digital health and data ecosystems in scaling access.
- Public–private partnerships for sustainable delivery models.
This session will provide a forward-looking perspective on how the industry can move beyond product innovation to create lasting health impact at scale.